Targeted therapy is a type of cancer treatment that uses drugs to specifically target and block the growth and spread of cancer cells. Here are some examples of targeted therapy medications that may be used for the treatment of stomach cancer:

• Trastuzumab (Herceptin):
  Trastuzumab is a targeted therapy medication that is used for the treatment of stomach cancers that overexpress the HER2 protein. It works by binding to the HER2 protein, which slows or stops the growth of cancer cells.
• Ramucirumab (Cyramza):
  Ramucirumab is a targeted therapy medication that is used for the treatment of advanced or metastatic stomach cancer. It works by blocking the formation of new blood vessels that supply oxygen and nutrients to cancer cells, which can slow or stop their growth.
• Pembrolizumab (Keytruda):
  Pembrolizumab is a targeted therapy medication that is used for the treatment of certain types of stomach cancer that are positive for PD-L1. It works by blocking the PD-L1 protein on cancer cells, which allows the immune system to recognize and attack the cancer cells.
• Regorafenib (Stivarga):
  Regorafenib is a targeted therapy medication that is used for the treatment of advanced or metastatic stomach cancer. It works by blocking certain enzymes and proteins that are involved in the growth and spread of cancer cells.

It’s important to note that the use of targeted therapy medications in the treatment of stomach cancer is highly individualized, and the specific medications and treatment plan will depend on the stage and type of the cancer, as well as the individual patient’s needs. A healthcare provider will determine the most appropriate treatment plan for each patient.

Immunotherapy is a type of cancer treatment that uses drugs to help the immune system recognize and attack cancer cells. Here are some examples of immunotherapy medications that may be used for the treatment of stomach cancer:

• Pembrolizumab (Keytruda):
  Pembrolizumab is an immunotherapy medication that is used for the treatment of certain types of stomach cancer that are positive for PD-L1. It works by blocking the PD-L1 protein on cancer cells, which allows the immune system to recognize and attack the cancer cells.
• Nivolumab (Opdivo):
  Nivolumab is an immunotherapy medication that is used for the treatment of advanced or metastatic stomach cancer. It works by blocking a protein called PD-1 on immune cells, which can help the immune system recognize and attack the cancer cells.
• Atezolizumab (Tecentriq):
  Atezolizumab is an immunotherapy medication that is used for the treatment of certain types of stomach cancer that are positive for PD-L1. It works by blocking the PD-L1 protein on cancer cells, which allows the immune system to recognize and attack the cancer cells.
• Ipilimumab (Yervoy):
  Ipilimumab is an immunotherapy medication that is used for the treatment of certain types of advanced or metastatic stomach cancer. It works by blocking a protein called CTLA-4 on immune cells, which can help the immune system recognize and attack the cancer cells.

It’s important to note that the use of immunotherapy medications in the treatment of stomach cancer is highly individualized, and the specific medications and treatment plan will depend on the stage and type of the cancer, as well as the individual patient’s needs. A healthcare provider will determine the most appropriate treatment plan for each patient.

Radiation therapy uses high-energy radiation to kill cancer cells. It may be used before or after surgery, or in combination with chemotherapy. Radiation therapy can help to shrink tumors and relieve symptoms of stomach cancer.